Self-amplifying RNA vaccines for infectious diseases.
Self-amplifying RNA vaccines for infectious diseases.
复制标题
DOI:
10.1038/s41434-020-00204-y
复制
发表时间:
2021-04
期刊:
影响因子:
5.1
通讯作者:
Arbuthnot P
中科院分区:
文献类型:
--
作者:
Bloom K;van den Berg F;Arbuthnot P
Vaccinology is shifting toward synthetic RNA platforms which allow for rapid, scalable, and cell-free manufacturing of prophylactic and therapeutic vaccines. The simple development pipeline is based on in vitro transcription of antigen-encoding sequences or immunotherapies as synthetic RNA transcripts, which are then formulated for delivery. This approach may enable a quicker response to emerging disease outbreaks, as is evident from the swift pursuit of RNA vaccine candidates for the global SARS-CoV-2 pandemic. Both conventional and self-amplifying RNAs have shown protective immunization in preclinical studies against multiple infectious diseases including influenza, RSV, Rabies, Ebola, and HIV-1. Self-amplifying RNAs have shown enhanced antigen expression at lower doses compared to conventional mRNA, suggesting this technology may improve immunization. This review will explore how self-amplifying RNAs are emerging as important vaccine candidates for infectious diseases, the advantages of synthetic manufacturing approaches, and their potential for preventing and treating chronic infections.
登录
查看更多内容
影响因子:
10.8
作者:
Blakney, Anna K.;McKay, Paul F.;Shattock, Robin J.
通讯作者:
Shattock, Robin J.
影响因子:
12.4
作者:
Erasmus, Jesse H.;Khandhar, Amit P.;Van Hoeven, Neal
通讯作者:
Van Hoeven, Neal
DOI:
10.1016/j.omtn.2018.04.019
发表时间:
2018-09-07
期刊:
Molecular therapy. Nucleic acids
影响因子:
--
作者:
Englezou PC;Sapet C;Démoulins T;Milona P;Ebensen T;Schulze K;Guzman CA;Poulhes F;Zelphati O;Ruggli N;McCullough KC
通讯作者:
McCullough KC
影响因子:
5.4
作者:
Aberle, JH;Aberle, SW;Mandl, CW
通讯作者:
Mandl, CW
影响因子:
64.8
作者:
通讯作者:
--